A January 2024 Forbes article highlights the crucial role firms like HEMEO play in optimizing the use of blood by clinicians. In the post-Covid era, when the number of people donating blood has decreased, innovative data-driven technologies like HEMEO offer a much-needed injection of optimism in addressing blood supply and management challenges.

To read the full article: www.forbes.com